Related Experiment Video

Updated: Aug 9, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Emerging reverse transcriptase inhibitors for the treatment of HIV infection in adults

Claude Fortin1, Véronique Joly, Patrick Yeni

  • 1Centre Hospitalier de l'Université de Montréal, UHRESS-Département de Microbiologie médicale et Infectiologie, Hôpital Notre-Dame, 1560, rue Sherbrooke Est, Montréal (Québec), H2L 4M1, Canada. claude.fortin.chum@ssss.gouv.qc.ca

Expert Opinion on Emerging Drugs
|April 26, 2006
PubMed

Insights

New highly active antiretroviral therapy (HAART) drugs are emerging to combat HIV. Research focuses on enhancing potency, reducing toxicity, and overcoming drug resistance for better patient outcomes.

Area of Science:

  • Virology
  • Pharmacology
  • Infectious Diseases

Background:

  • Highly active antiretroviral therapy (HAART) is the standard of care for HIV treatment.
  • 21 antiretroviral drugs are currently available, categorized into four main classes.
  • Emerging HIV drugs target novel viral proteins or existing viral targets.

Purpose of the Study:

  • To review emerging drugs designed to inhibit the reverse transcriptase of HIV.
  • To highlight key considerations in developing new antiretroviral drugs within existing classes.

Main Methods:

  • Review of preclinical and clinical development of novel anti-HIV compounds.
  • Analysis of strategies for optimizing drug potency and minimizing toxicity.
  • Examination of approaches to overcome drug resistance and reduce pill burden.

Main Results:

  • Focus on developing potent, less toxic drugs with reduced resistance risk.
  • Emphasis on creating effective treatments for patients with existing drug resistance.
  • Goal of once-daily dosing to improve patient adherence and reduce costs.

Conclusions:

  • Emerging HIV drugs aim to improve upon current HAART regimens.
  • Development priorities include enhanced efficacy, safety, and patient convenience.
  • Continued research is crucial for addressing HIV treatment challenges.

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells13:07

Determining 3'-Termini and Sequences of Nascent Single-Stranded Viral DNA Molecules during HIV-1 Reverse Transcription in Infected Cells

Published on: January 30, 2019

Related Concept Videos

Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Size and Structure of Viral Genomes01:26

Size and Structure of Viral Genomes

Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...